Dr. George Georgiou
Dr. George Georgiou
Department of Chemical Engineering
Department of Molecular Biosciences
Department of Biomedical Engineering
Department of Oncology
gg[at]che.utexas.edu
The University of Texas at Austin
Austin, TX 78712
Find out more about the Research projects currently active in the Georgiou group.
Find out about features and highlights of the groundbreaking research from the Georgiou lab.
Have questions? See here for the methods of getting in contact with the Georgiou lab.
Graduate Researcher Norah Ashoura wins the Science in Plain English contest, sponsored by UT’s Science Communications Interest Group, by giving remarks comparing cancer to Darth Vader and the hapless immune system to Jedi Knights in the Star Wars universe. She won a trip to one of the largest gatherings of scientists, which is happening this week, the annual meeting for the American Association for the Advancement of Science (AAAS).
https://cns.utexas.edu/news/fight-cancer-she-must
The November Nature Medicine issue focused on recent progress in influenza vaccine research, and published two critical papers from our group highlighting how influenza vaccines may be improved.
http://www.nature.com/nm/journal/v22/n12/abs/nm.4224.html
http://www.nature.com/nm/journal/v22/n12/abs/nm.4223.html
https://www.sciencedaily.com/releases/2016/11/161115145854.htm
http://che.utexas.edu/2016/11/15/flu-vaccines-effectiveness-can-be-improved/
George Georgiou, a professor of engineering and molecular biosciences at the University of Texas at Austin, and his colleagues have developed a hybrid antibody that neutralized 99 percent of HIV-1 strains tested. The antibody is based on so-called “broadly-neutralizing antibodies,” a group of antibodies from HIV-infected patients that are able to take down an array of rapidly mutating HIV-1 viruses.
The research was published last week in the journal Science Immunology.
https://cns.utexas.edu/news/hybrid-antibody-takes-down-hiv
https://news.utexas.edu/2016/11/15/new-findings-on-flu-vaccines-effectiveness
A research team led by scientists at The University of Texas Austin has engineered an enzyme that safely treats prostate and breast cancer in animals and also lengthens the lifespan of models that develop chronic lymphocytic leukemia. The new treatment and results from preclinical trials are described in a paper published in the Nov. 21 issue of Nature Medicine.
https://news.utexas.edu/2016/12/09/enzyme-starves-cancer-cells
Congratulations to Dr. Scott Kerr who has accepted a position at BioFire Diagnostics!
Congratulations to Dr. Daechan Park who has accepted a position at KIST (Korea Institute of Science and Technology)!
Congratulations to alum Dr. Ki Jun Jeong on his promotion to Associate Professor with Tenure at KAIST! http://proteineng.cafe24.com/xe/
Congratulations to Ahlam Qerqez who has been accepted to the graduate program at UT Austin in the Chemical Engineering Department. Ahlam will join alum Jennifer Maynard’s lab. https://sites.google.com/site/maynardlabatut/Home